Skip to content
Screener

Alkermes ALKS Shares (Diluted)

Shares (Diluted) at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
66.1M+8.4%
AbbVie logo
AbbVieABBV
1.8B0.0%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
51.2M+4.8%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
129M+3.2%
LBR
LB Pharmaceuticals IncLBRX
28.2M+7,772%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
58.8M+0.4%

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.32B+89.9%
Enterprise value$9.38B+139%
P/E125.9×+113×
P/S+2.1×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
(Loss) earnings per ordinary share—diluted$0.00$0.52$(0.40)$0.65
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES OUTSTANDING:
Basic167,026164,959166,613164,188
Diluted173,478168,357166,613168,470
COMPREHENSIVE (LOSS) INCOME:
Net (loss) income$501$87,098$(65,979)$109,562
Holding (loss) gain, net of a tax (benefit) provision of $78, $16, $249 and $184, respectively(255)55(823)567
Foreign currency translation gain240

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's shares (diluted)?
Alkermes (ALKS) reported shares (diluted) of 173.5M in Q2 2026.
How has Alkermes's shares (diluted) changed year-over-year?
Alkermes's shares (diluted) increased by 3.0% year-over-year, from 168.4M to 173.5M.
What is the long-term trend for Alkermes's shares (diluted)?
Over 4 years (2021 to 2025), Alkermes's shares (diluted) has grown at a 0.9% compound annual growth rate (CAGR), from 649.8M to 674.3M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Alkermes's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude